Showing results (651-660 of 796) with videos related to
Sort By:
Pageof 80
Cell Death and Differentiation|August 22, 2009
Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cellsS Romano, A D'Angelillo, R Pacelli, et al.Cell Death and Differentiation|November 5, 2011
A set of miRNAs participates in the cellular senescence program in human diploid fibroblastsR Faraonio, P Salerno, F Passaro, et al.Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|February 24, 2001
[Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation]S Romano, L Fattore, G Toscano, et al.JCI Insight|May 14, 2021
Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infectionXiaomo Li, Sijia Yi, Débora B Scariot, et al.Archives of Surgery (Chicago, Ill. : 1960)|February 18, 2009
Hospital teaching intensity, patient race, and surgical outcomesJeffrey H Silber, Paul R Rosenbaum, Patrick S Romano, et al.Journal of Medical Systems|September 8, 2020
Repurposing Clinical Decision Support System Data to Measure Dosing Errors and Clinician-Level Quality of CareDavid L Chin, Michelle H Wilson, Ashley S Trask, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 25, 2013
Relative bioavailability of isoniazid in a fixed-dose combination product in healthy Mexican subjectsR C Milán-Segovia, M Vigna-Pérez, M C Romero-Méndez, et al.Journal of the American College of Surgeons|April 9, 2011
How valid is the AHRQ Patient Safety Indicator "postoperative respiratory failure"?Ann M Borzecki, Haytham M A Kaafarani, Garth H Utter, et al.Molecular Biology Reports|August 29, 2014
Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo populationR Salazar-González, R Gómez, S Romano-Moreno, et al.Scientific Reports|April 8, 2017
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsC Eleuteri, S Olla, C Veroni, et al.Pageof 80